{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:34:31Z","timestamp":1760888071818},"reference-count":34,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.ijpharm.2007.03.045","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T18:20:47Z","timestamp":1177525247000},"page":"50-57","source":"Crossref","is-referenced-by-count":13,"title":["In vitro and in vivo study of poly(ethylene glycol) conjugated ketoprofen to extend the duration of action"],"prefix":"10.1016","volume":"341","author":[{"given":"Hoo-Kyun","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Kwan","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mee Hee","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Doo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Sik","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seaung Youl","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2007.03.045_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0168-3659(96)01319-3","article-title":"Pharmacokinetic and pharmacodynamic profile of triethylene glycol indomethacin ester as a new oral prodrug","volume":"41","author":"Bonina","year":"1996","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejpb.2004.02.012","article-title":"Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug","volume":"58","author":"Cavallaro","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/10611860400013477","article-title":"Glycosilated macromolecular conjugates of antiviral drugs with a polyaspartamide","volume":"12","author":"Cavallaro","year":"2004","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib4","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/aic.10848","article-title":"Ketoprofen nanoparticle gels formed by evaporative precipitation into aqueous solution","volume":"52","author":"Chen","year":"2006","journal-title":"AIChE J."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0168-3659(02)00078-0","article-title":"Mucoadhesive drug carrier based on interpolymer complex of poly(vinyl pyrrolidone) and poly(acrylic acid) prepared by template polymerization","volume":"81","author":"Chun","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib6","first-page":"74","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D\u2019Amour","year":"1941","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib7","first-page":"652","article-title":"Antinociceptive activity of the narcotic antagonist analgesics and antagonistic activity of narcotic analgesics in rodents","volume":"179","author":"Dewey","year":"1971","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib8","first-page":"374","article-title":"Synthesis and biological evaluation of ketoprofen glycinate methyl ester: a prodrug concept. Part I","volume":"31","author":"Dhaneshwar","year":"1994","journal-title":"Indian Drugs"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-3659(01)00292-9","article-title":"Pegylation enhances protein stability during encapsulation in PLGA microspheres","volume":"73","author":"Diwan","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib10","first-page":"53","article-title":"Soluble synthetic polymers as potential drug carriers","volume":"57","author":"Duncan","year":"1984","journal-title":"Adv. Polym. Sci."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0168-3659(92)90088-9","article-title":"Preclinical evaluation of polymer-bound doxorubicin","volume":"19","author":"Duncan","year":"1992","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib12","first-page":"69","article-title":"The current status of solid dispersions","volume":"61","author":"Ford","year":"1986","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0168-3659(90)90127-F","article-title":"The clinical efficacy of poly(ethylene glycol)-modified proteins","volume":"11","author":"Fuertges","year":"1990","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0169-409X(91)90036-C","article-title":"Therapeutic proteins\u2014a pharmaceutical perspective","volume":"6","author":"Goddard","year":"1991","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib15","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1023\/A:1011945704248","article-title":"PEGylation prevents the N-terminal degradation of megakaryocyte growth and development factor","volume":"15","author":"Guerra","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0169-409X(02)00025-X","article-title":"Effects of PEG conjugation on insulin properties","volume":"54","author":"Hinds","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1023094629718","article-title":"Prolonged plasma levels of ketoprofen after oral administration of its \u03b1-cyclodextrin conjugate\/ethylcellulose dispersion in rats","volume":"44","author":"Hirayama","year":"2002","journal-title":"J. Incl. Phenom. Macro."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib19","series-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","first-page":"617","article-title":"Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout","author":"Insel","year":"1996"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib20","first-page":"71","article-title":"Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig","volume":"3","author":"Larsen","year":"1991","journal-title":"Acta Pharm. Nord."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1023\/A:1018861616465","article-title":"Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins","volume":"16","author":"Lee","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib22","first-page":"308","article-title":"Analysis of bioequivalence study using a log-transformed model","volume":"44","author":"Lee","year":"2000","journal-title":"Yakhakhoeji"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0168-3659(95)00141-7","article-title":"Macromolecular prodrugs of 5-fluorouracil. 2. Enzymatic degradation","volume":"39","author":"Nichifor","year":"1996","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0169-409X(91)90037-D","article-title":"The therapeutic value of poly(ethylene glycol)-modified proteins","volume":"6","author":"Nucci","year":"1991","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/10915819309141598","article-title":"Final report on the safety assessment of polyethylene glycols (PEGs)-6, -8, -32, -75, -150, -14M, -20M","volume":"12","author":"Pang","year":"1993","journal-title":"J. Am. Coll. Toxicol."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0169-409X(91)90038-E","article-title":"Preparation, in vivo properties and proposed clinical use of polyoxyethylene-modified tissue plasminogen activator and streptokinase","volume":"6","author":"Pizzo","year":"1991","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0378-5173(97)00380-3","article-title":"Investigation of antinociceptive efficacy and relative potency of extended duration injectable 3-acylmorphine-6-sulfate prodrugs in rats","volume":"163","author":"Preechagoon","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1200\/JCO.2003.03.143","article-title":"A Phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies","volume":"21","author":"Rowinsky","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(97)01434-9","article-title":"Characterization of neonatal rat morphine tolerance and dependence","volume":"340","author":"Thornton","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1517\/13543776.14.6.859","article-title":"Protein, peptide and nonpeptide drug PEGylation for therapeutic application: a review","volume":"14","author":"Veonese","year":"2004","journal-title":"Expert Opin. Ther. Patents"},{"key":"10.1016\/j.ijpharm.2007.03.045_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/088391159901400504","article-title":"pH sensitive polymeric prodrugs containing ibuprofen, ketoprofen and naproxen as pendent groups","volume":"14","author":"Wang","year":"1999","journal-title":"J. Bioact. Compat. Pol."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ijpharm.2007.03.045_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejps.2004.09.001","article-title":"Improvement of warfarin biopharmaceutics by conjugation with poly(ethylene glycol)","volume":"23","author":"Zacchigna","year":"2004","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517307002876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517307002876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:53:51Z","timestamp":1546908831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517307002876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":34,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0378517307002876"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2007.03.045","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}